Active Shortage

POTASSIUM PHOSPHATE MONOBASIC INJECTION

SANDOZ CANADA INCORPORATED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of POTASSIUM PHOSPHATE MONOBASIC INJECTION in Canada?

Yes. POTASSIUM PHOSPHATE MONOBASIC INJECTION 176MG has an active shortage reported to Health Canada (last updated June 4, 2026).

When will POTASSIUM PHOSPHATE MONOBASIC INJECTION be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Affected strength176MG

Last updated2026-06-04

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

00711306

Strength

176MG

Dosage Form

SOLUTION LIQUID

Route

INTRAVENOUS

Active Ingredient

POTASSIUM PHOSPHATE MONOBASIC

Tier

Unrated

Last Updated

2026-06-04

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929